A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: a study protocol
Abstract Background The current standard treatment for resectable pancreatic cancer is surgical resection followed by adjuvant chemotherapy. Local recurrence rates are high even after curative resection; thus, the long-term outcome of locally advanced pancreatic cancer remains poor. Intraoperative r...
Main Authors: | Jun Won Kim, Yeona Cho, Hyung Sun Kim, Won Hoon Choi, Joon Seong Park, Ik Jae Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12893-019-0492-x |
Similar Items
-
Using the new INTRABEAM mobile intraoperative radiotherapy system during surgery for pancreatic cancer: a case report
by: Xiaodong Song, et al.
Published: (2019-01-01) -
Use of Intraoperative Radiotherapy in Pancreatic Cancer After Neoadjuvant Chemoradiotherapy: First National Application
by: Emin KÖSE, et al.
Published: (2016-12-01) -
The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis
by: Liang Jin, et al.
Published: (2020-04-01) -
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer
by: Felipe A. Calvo, et al.
Published: (2020-07-01) -
Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
by: Carsten Herskind, et al.
Published: (2017-07-01)